In the wake of concerns over adverse drug reactions linked to certain medicines, including the recent Coldrif syrup controversy, the Punjab government has ordered the immediate discontinuation of eight intravenous drugs and fluids manufactured by three pharmaceutical companies.

In a circular issued by the Directorate of Health and Family Welfare, all civil surgeons, medical superintendents and district hospital heads have been directed to stop the use, issue and procurement of the listed drugs and fluids with immediate effect. The order, dated October 10, said the move followed reports of suspected cases of adverse drug reactions from some health facilities. As a precautionary measure, the state has decided to suspend the use of the identified batches until further orders.

The directive

See Full Page